Results 231 to 240 of about 16,593 (260)

αFAP-specific nanobodies mediate a highly precise retargeting of modified AAV2 capsids thereby enabling specific transduction of tumor tissues

Olaniyi Olarewaju, Franziska Held, Peter J. Curtis, Cynthia Hess Kenny, Udo Maier, Tadas Panavas, Francois du Plessis   +6 more
openalex   +1 more source

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22

Scott McComb, Mehdi Arbabi‐Ghahroudi, Kevin A. Hay, Brian A. Keller, Sharlene Faulkes, Michael Rutherford, Tina Nguyen, Alex Shepherd, Cunle Wu, Anne Marcil, Annie Aubry, Greg Hussack, Devanand M. Pinto, Shannon Ryan, Shalini Raphael, Henk van Faassen, Ahmed Zafer, Qin Zhu, Susanne MacLean, Anindita Chattopadhyay, Komal Gurnani, Rénald Gilbert, Christine Gadoury, Umar Iqbal, Dorothy Fatehi, Anna Jezierski, Jez Huang, Robert A. Pon, Mhairi K. Sigrist, Robert A. Holt, Brad H. Nelson, Harold Atkins, Natasha Kekre, Eric Yung, John K. Webb, Julie S. Nielsen, Risini D. Weeratna   +36 more
openalex   +1 more source

Machine learning enables efficient and effective affinity maturation of nanobodies

Steffan B. Paul, Edward P. Harvey, James Osei-Owusu, Aaron W. Kollasch, Adam J. Riesselman, Conor McMahon, Artem Gazizov, Murali Anuganti, Filmawit Belay, Minh Anh Kieu, Haisun Zhu, L Robert Hollingsworth, J Wade Harper, Deborah Moshinsky, Andre Razevedo Reis Teixeira, debora marks, Andrew C Kruse   +16 more
openalex   +1 more source

US28 nanobodies

, 2020
openaire   +1 more source

VGluT1 nanobody is specific for VGluT1 but not for VGluT2.

Yeasmin Akter (7378415), Grace Jones (1840372), Grant J. Daskivich (21001625), Victoria Shifflett (21001628), Karina J. Vargas (21001631), Martin Hruska (355590)   +5 more
openalex   +1 more source

Raw data for "Targeting mGlyR with nanobodies for depression".

Martemyanov, Kirill, Laboute, Thibaut, Zucca, Stefano, Sial, Omar K., Sharma, Mansi, Brunori, Gloria, Singh, Shikha, Nageswar, KV, Peng, Haiyong, Rader, Christoph, AJ Becker, Jérôme, Le Merrer, Julie, Singh, Appu K.   +12 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Applications of Nanobodies

Annual Review of Animal Biosciences, 2021
Unique, functional, homodimeric heavy chain–only antibodies, devoid of light chains, are circulating in the blood of Camelidae. These antibodies recognize their cognate antigen via one single domain, known as VHH or Nanobody. This serendipitous discovery made three decades ago has stimulated a growing number of researchers to generate highly specific ...
openaire   +2 more sources

Nanobody against PDL1

Biotechnology Letters, 2020
Programmed death ligand 1 (PDL1, CD274, B7-H1) has been identified as the ligand for the immune inhibitory receptor programmed death 1 protein (PD1/PDCD1). PDL1 is a member of B7 family of immune molecules and this protein together with PDL2, are two ligands for PD1 expressed on activated lymphoid cells. By binding to PD1 on activated T cells, PDL1 may
Shufeng Li, Kunpeng Jiang, Ting Wang, Wei Zhang, Minke Shi, Baojun Chen, Zichun Hua   +6 more
openaire   +2 more sources

Immuno-imaging using nanobodies

Current Opinion in Biotechnology, 2011
Immuno-imaging is a developing technology that aims at studying disease in patients using imaging techniques such as positron emission tomography in combination with radiolabeled immunoglobulin derived targeting probes. Nanobodies are the smallest antigen-binding antibody-fragments and show fast and specific targeting in vivo.
Vaneycken, Ilse, D'Huyvetter, Matthias, Hernot, Sophie, De Vos, Jens, Xavier, Catarina, Devoogdt, Nick, Caveliers, Vicky, Lahoutte, Tony   +7 more
openaire   +3 more sources

Nanobody-Based Chromatin Immunoprecipitation

2012
Chromatin immunoprecipitation (ChIP), followed by microarray hybridization (ChIP-chip) or high-throughput sequencing (ChIP-seq), is becoming a widely used powerful method for the analysis of the in vivo DNA-protein interactions at genomic scale.The success of ChIP largely depends on the quality of antibodies.
NGUYEN DUC, Trong, Hassanzadeh Ghassabeh, Gholamreza, Saerens, Dirk, Peeters, Eveline, Charlier, Daniel, Muyldermans, Serge   +5 more
openaire   +3 more sources